Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. - Wikidata - wikimedia - TriplyDB

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

http://www.wikidata.org/entity/Q42447268

about

Cardiac regulation by phosphoinositide 3-kinases and PTEN Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA Phosphoinositides: tiny lipids with giant impact on cell regulation PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damage The Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and Inflammation Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice Insulin Signaling and Heart Failure.Genetics of hypertension: discoveries from the bench to human populations.Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs)PI3Kgamma protects from myocardial ischemia and reperfusion injury through a kinase-independent pathway.Protective Role for LPA3 in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol.Distinct functions of junD in cardiac hypertrophy and heart failure Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation.β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy.The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.Carvedilol reverses cardiac insufficiency in AKAP5 knockout mice by normalizing the activities of calcineurin and CaMKII.Cardiac phenotype induced by a dysfunctional α 1C transgene: a general problem for the transgenic approach Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling.Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart.Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.Insulin-like growth factor 1 prevents diastolic and systolic dysfunction associated with cardiomyopathy and preserves adrenergic sensitivity Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.Insulin signaling pathways and cardiac growth.Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning Tripartite motif 32 prevents pathological cardiac hypertrophy Flavonoids Extraction from Propolis Attenuates Pathological Cardiac Hypertrophy through PI3K/AKT Signaling Pathway.Myocardial AKT: the omnipresent nexus.Surgical ventricular reconstruction in mice: elucidating potential targets for combined molecular/surgical intervention.Ginsenoside rb1 reduces isoproterenol-induced cardiomyocytes apoptosis in vitro and in vivo.Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.Rodent models of heart failure: an updated review.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.

P2860

Q24317248-1D471F32-4C2E-43FE-B0B8-B2824F4CBFA8 Q24632097-C98B114C-63AD-4794-AA6D-25D37A8A48A4 Q27012953-EBC22921-6DA4-46AA-AF05-AD78A52F8683 Q27026365-CE1AFCD4-236C-4BF0-86BB-C3656FB06C26 Q28066576-1F2475CA-8F3D-4D7C-BCC2-C31391F1CB4E Q28484372-36F9DAEA-A3D6-4925-86FF-DAE504922E4A Q28487365-4F6E9624-5A0C-43EC-937A-C0EA08BBFA76 Q28585152-699CEA4F-8FE1-4D44-8D10-3868B558E26D Q30377910-94AA096D-E7D8-4988-AFD8-95B75A836327 Q30408743-24EC7F8A-F9F6-4DC6-B07D-8BC94B52FCC7 Q30557755-C29FCF32-A9A0-447C-BDCB-32239D3EFB9A Q33533748-DB067458-5178-4303-86D6-51950D8429B7 Q33736651-35050E26-0EA3-47D7-BA2C-294F98AA40DA Q33763691-B06D31A0-9C00-42A5-8E48-50D120F2B632 Q33872909-6A1CD35A-29B7-4543-9E1A-FE970851F773 Q34058699-233475D3-7A9E-43F2-9C2C-53F48703E429 Q34100575-19F14F56-684A-4D65-BBB0-D7ACC4FB8AD9 Q34421837-5DDD9314-880F-4A5E-AF07-725A94678458 Q34498911-00F7C53C-F3BD-4230-B045-A83B1C53D1C1 Q34974506-A39BF31E-02EB-4EA0-804E-D6C068E4B080 Q35079048-6EFCB724-2D13-4B62-A158-1C958E20B922 Q35983836-9B6AACD6-9E4D-44EF-9ED8-D3E119E2984C Q36061754-C0327165-A097-4232-A682-69D7C5CAF1CB Q36241862-6FB8A56B-C3B2-43A4-8327-89C2CB875E03 Q36575695-D0198BC9-0F57-4522-97B9-862185E043CE Q36649830-550D6738-2B46-4126-8AD2-A21706328C18 Q36702291-9E1DCC4C-CDF3-4C50-9BC4-074FAFF08E43 Q36742620-AA86B4BE-9FAC-4CDE-8356-DB2F96A7CEE0 Q36787700-A4CC9E46-FDCB-443B-BBB9-3C5B88822314 Q36842050-60FCB162-9017-48AA-B989-BA51305D54BE Q36880827-A8F475E9-19FC-4623-AF7B-E64335B9C6AD Q36908289-7B06B264-267F-40FD-AC38-5AF1B3DC91FC Q37217749-B4BEB8C3-62B4-48D4-8D3B-314ACFB45571 Q37365912-DAF697C2-5121-4CD5-BEFB-D789510200B5 Q37831634-F338A96F-77C7-4C33-BA24-3D8127522E84 Q37833892-BAFBC1B0-5925-4C23-B144-A7AE5B5A6BEB Q37883418-6567A3EC-AB08-4302-A57E-42B5D004145F Q37951309-8408A7BB-5A72-4715-9F64-07F2A404DA06 Q37996857-748F2893-38B5-478D-8042-29BE61E7F4A3 Q38100223-59856F4C-FC8A-4C6A-9FCB-48BAC3A7C01C

P2860

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

http://www.wikidata.org/entity/Q42447268

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@en

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@nl

type

label

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@en

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@nl

prefLabel

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@en

Phosphoinositide 3-kinase gamm ...... terenol-induced heart failure.

@nl

P1433

Q42447268-F0C21D94-3AB1-4326-A038-159B066354F1

P1476

Q42447268-C0A26133-6656-4DD1-BE11-BF7BBD30EBCB

P2093

Q42447268-30709401-6953-4B4E-8267-0EA077254A2C

Q42447268-38572619-AA0C-4057-BDA1-1DC6D4E2BA9B

Q42447268-388879D1-6F15-4E68-8C13-B12B8F0695E9

Q42447268-58FAC657-B14D-40DF-9E88-F451E5864EE4

Q42447268-5B207CDC-3F7C-490B-AC23-5061F51380D8

Q42447268-61204E71-6BDF-470C-A690-FDCF365307E1

Q42447268-710FE4F4-CA44-4F50-8B9C-C7C3AABDA1FF

Q42447268-931AAFD7-8093-4C2A-B7B9-224D2DE2D62B

Q42447268-9819D809-B7EF-4A0A-835D-6E323D897688

Q42447268-DCA41E68-3B01-467E-9500-3C7CCF5E8632

P304

Q42447268-F2E1696D-2B93-4922-B25B-5B39A3035CA0

P31

Q42447268-D654CF43-9240-48D5-8E8C-E23ED0EEE61C

P356

Q42447268-AC35D526-6A7A-46F4-8AC9-DC53652AD445

P407

Q42447268-3EDEDED0-EA5F-40EB-82FC-104904208B34

P433

Q42447268-A294F175-94D7-4988-8495-14A726344AF3

P478

Q42447268-8E5004D1-7EC1-4DD0-86F5-EB3F4B3585B6

P50

Q42447268-0EACD722-5421-4DAB-946F-82581103B1B0

Q42447268-39BB3808-CCFB-4F02-B987-8D214A2BB0F4

Q42447268-6571EE62-14BA-46F3-8190-646113B4C912

P577

Q42447268-74E1F181-4E13-478A-A90C-C3B3821F9255

P5875

Q42447268-1870E5E0-09E0-4C1C-BA27-AAE71A13B635

P698

Q42447268-1169C22A-14B1-439C-B3F0-FF479A2BFAC7

P356

01.CIR.0000091403.62293.2B

P1433

P1476

Phosphoinositide 3-kinase gamm ...... oterenol-induced heart failure

@en

P2093

Dominica Gidrewicz

http://www.w3.org/2001/XMLSchema#string

Gavin Y Oudit

http://www.w3.org/2001/XMLSchema#string

Ivona Kozieradzki

http://www.w3.org/2001/XMLSchema#string

Junko Irie-Sasaki

http://www.w3.org/2001/XMLSchema#string

Michael A Crackower

http://www.w3.org/2001/XMLSchema#string

Peter H Backx

http://www.w3.org/2001/XMLSchema#string

Renu Sarao

http://www.w3.org/2001/XMLSchema#string

Susan F Steinberg

http://www.w3.org/2001/XMLSchema#string

Teiji Wada

http://www.w3.org/2001/XMLSchema#string

Vitalyi O Rybin

http://www.w3.org/2001/XMLSchema#string

P304

2147-2152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000091403.62293.2B

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

Takehiko Sasaki

P577

2003-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10575644

http://www.w3.org/2001/XMLSchema#string

P698

12963636

http://www.w3.org/2001/XMLSchema#string